Results 131 to 140 of about 19,315 (197)

The efficacy and safety of ticagrelor and prasugrel versus clopidogrel in post-PCI dual antiplatelet therapy in chronic coronary syndrome: a systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord
Mirhosseini SA, Mousavi A, Dastjerdi P, Abdollahi M, Yazdanpanah H, Barahimi M, Mirzaei A, Moshfeghinia R, Ranjbar M, Azami P, Abdollahi A, Bakhshi H, Attar A.   +12 more
europepmc   +1 more source

Drug repurposing of ticagrelor suppresses renal cell carcinoma growth by blockading the EGFR/PI3K/AKT axis. [PDF]

Ann Med
Yang Y, Zhang L, Guo Y, Zhou T, Liu T, Fang H, He Y.   +6 more
europepmc   +1 more source

Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib. [PDF]

Eur Heart J Case Rep
Dirir O, Parker WAE, Haley HA, Gunn JP, Storey RF.   +4 more
europepmc   +1 more source

Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes. [PDF]

Acta Neurochir (Wien)
Li C, Yuan H, Duan C, Feng X, Liu W, Huang J, Huang C, Huang M, Wen Z, Ge R, Lin J, Jin F, Li R, Guo S, Chen C, Liang S, Li X.   +16 more
europepmc   +1 more source

Early aspirin withdrawal versus dual antiplatelet therapy in high-risk patients after percutaneous coronary intervention: Meta-analysis of randomized trials. [PDF]

PLoS Med
Navarese EP, Gurbel P, Tantry U, Talanas G, Grzelakowska K, Umińska J, Jeong YH, Bliden K, Khan SU, Kubica J, Henry TD, Farkouh ME, Kereiakes DJ.   +12 more
europepmc   +1 more source

Safety and efficacy of flow diversion for blood blister aneurysms: A comprehensive systematic review and meta-analysis. [PDF]

Neurosurg Rev
Maroufi SF, Fallahi MS, Thomas AJ, Tonetti DA.   +3 more
europepmc   +1 more source

Risk of clopidogrel resistance in endovascular aneurysm stenting. [PDF]

Surg Neurol Int
Stanton M, Ng W, Jonathan A.
europepmc   +1 more source

Thrombocytosis-associated ticagrelor non-responder status after ECMO-supported primary PCI in STEMI. [PDF]

J Cardiol Cases
Strohhofer C, Alber H, Dörler J.
europepmc   +1 more source

The performance of ASpirin-FREE therapy after successful percutaneous coronary intervention for acute coronary syndrome: the ASFREE prospective pilot study. [PDF]

J Yeungnam Med Sci
Joo D, Jo S, Byoun JT, Cho JY, Yun KH.
europepmc   +1 more source

Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study. [PDF]

Front Cardiovasc Med
Wanda M, Mengjie L, Jingyao W, Xue S, Xiao W, Cairong L, Yachao L, Zhigang Z, Zengming X.   +8 more
europepmc   +1 more source